lenvatinibatezolizumab-bevacizumabdurvalumabtremelimumabHepatocellular carcinomaRimini et alAhn et alimmunotherapyHCCsystemic therapies
… the cornerstone of treatment for advanced-stage disease. While lenvatinib has been a widely used first-line agent, the advent of immunoth…